Combination of D-dimer level and neutrophil to lymphocyte ratio predicts long-term clinical outcomes in acute coronary syndrome after intervention

被引:4
作者
Gu, Ling-Feng [1 ]
Gu, Jie [1 ]
Wang, Si-Bo [1 ]
Wang, Hao [1 ]
Wang, Ya-Xin [1 ]
Xue, Yuan [1 ]
Wei, Tian-Wen [1 ]
Sun, Jia-Teng [1 ]
Lian, Xiao-Qing [1 ]
Liu, Jia-Bao [1 ]
Jia, En-Zhi [1 ,2 ]
Wang, Lian-Sheng [1 ,2 ]
机构
[1] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Peoples R China
[2] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
acute coronary syndrome; D-dimer; neutrophil to lymphocyte ratio; long-term outcome; percutaneous coronary intervention; ELEVATION MYOCARDIAL-INFARCTION; ST-SEGMENT ELEVATION; BLOOD-CELL SUBTYPES; FIBRIN D-DIMER; UNSTABLE ANGINA; MECHANISMS; DISEASE; ATHEROSCLEROSIS; APOPTOSIS; PROTEIN;
D O I
10.5603/CJ.a2021.0097
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: High D-dimer (DD) is associated with short-term adverse outcomes in patients with acute coronary syndrome (ACS). In ACS patients who underwent percutaneous coronary intervention (PCI), however, the value of DD (or combined with neutrophil to lymphocyte ratio [NLR]) to predict long-term major adverse cardiovascular events (MACEs) has not been fully evaluated. Methods: Patients diagnosed with ACS and receiving PCI were included. The primary outcome was MACEs. Cox proportional hazards regression and logistic regression were used to illustrate the relationship between clinical risk factors, biomarkers and MACEs. Survival models were developed based on significant factors and evaluated by the Concordance-index (C-index). Results: The final study cohort was comprised of 650 patients (median age, 64 years; 474 males), including 98 (15%) with MACEs during a median follow-up period of 40 months. According to the cut-off value of DD and NLR, the patients were separated into four groups: high DD or nonhigh DD with high or nonhigh NLR. After adjusting for confounding variables, DD (adjusted hazard ratio [aHR]: 2.39, 95% confidence interval [CI]: 1.52-3.76) and NLR (aHR: 2.71, 95% CI: 1.78-4.11) were independently associated with long-term MACEs. Moreover, patients with both high DD and NLR had a significantly higher risk in MACEs when considering patients with nonhigh DD and NLR as reference (aHR: 6.19, 95% CI: 3.30-11.61). The area under curve increased and reached 0.70 in differentiating long-term MACEs when DD and NLR were combined, and survival models incorporating the two exhibited a stronger predictive power (C-index: 0.75). Conclusions: D-dimer (or combined with NLR) can be used to predict long-term MACEs in ACS patients undergoing PCI. (Cardiol J)
引用
收藏
页码:576 / 586
页数:11
相关论文
共 36 条
[1]   Relative lymphocyte count: A prognostic indicator of mortality in elderly patients with congestive heart failure [J].
Acanfora, D ;
Gheorghiade, M ;
Trojano, L ;
Furgi, G ;
Pasini, E ;
Picone, C ;
Papa, A ;
Iannuzzi, GL ;
Bonow, RO ;
Rengo, F .
AMERICAN HEART JOURNAL, 2001, 142 (01) :167-173
[2]   Predictive value of elevated D-dimer in patients undergoing primary angioplasty for ST elevation myocardial infarction [J].
Akgul, Ozgur ;
Uyarel, Huseyin ;
Pusuroglu, Hamdi ;
Gul, Mehmet ;
Isiksacan, Nilgun ;
Turen, Selahattin ;
Erturk, Mehmet ;
Surgit, Ozgur ;
Cetin, Mustafa ;
Bulut, Umit ;
Baycan, Omer F. ;
Uslu, Nevzat .
BLOOD COAGULATION & FIBRINOLYSIS, 2013, 24 (07) :704-710
[3]   D-Dimer Levels and Effect of Rivaroxaban on Those Levels and Outcomes in Patients With Acute Coronary Syndrome (An ATLAS ACS-TIMI 46 Trial Substudy) [J].
AlKhalfan, Fahad ;
Kerneis, Mathieu ;
Nafee, Tarek ;
Yee, Megan K. ;
Chi, Gerald ;
Plotnikov, Alexei ;
Braunwald, Eugene ;
Gibson, C. Michael .
AMERICAN JOURNAL OF CARDIOLOGY, 2018, 122 (09) :1459-1464
[4]  
Amsterdam EA, 2014, CIRCULATION, V130, pE344, DOI [10.1161/CIR.0000000000000134, 10.1016/j.jacc.2014.09.017, 10.1016/j.jacc.2014.09.016, 10.1016/j.jacc.2014.10.011]
[5]   Role of polymorphonuclear neutrophils in atherosclerosis: Current state and future perspectives [J].
Baetta, Roberta ;
Corsini, Alberto .
ATHEROSCLEROSIS, 2010, 210 (01) :1-13
[6]   Usefulness of Neutrophil-to-Lymphocyte Ratio in Risk Stratification of Patients With Advanced Heart Failure [J].
Benites-Zapata, Vicente A. ;
Hernandez, Adrian V. ;
Nagarajan, Vijaiganesh ;
Cauthen, Clay A. ;
Starling, Randall C. ;
Tang, W. H. Wilson .
AMERICAN JOURNAL OF CARDIOLOGY, 2015, 115 (01) :57-61
[7]   Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease [J].
Besler, Christian ;
Heinrich, Kathrin ;
Rohrer, Lucia ;
Doerries, Carola ;
Riwanto, Meliana ;
Shih, Diana M. ;
Chroni, Angeliki ;
Yonekawa, Keiko ;
Stein, Sokrates ;
Schaefer, Nicola ;
Mueller, Maja ;
Akhmedov, Alexander ;
Daniil, Georgios ;
Manes, Costantina ;
Templin, Christian ;
Wyss, Christophe ;
Maier, Willibald ;
Tanner, Felix C. ;
Matter, Christian M. ;
Corti, Roberto ;
Furlong, Clement ;
Lusis, Aldons J. ;
von Eckardstein, Arnold ;
Fogelman, Alan M. ;
Luescher, Thomas F. ;
Landmesser, Ulf .
JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (07) :2693-2708
[8]   MECHANISMS OF DISEASE The Hemostatic System as a Modulator of Atherosclerosis [J].
Borissoff, Julian Ilcheff ;
Spronk, Henri M. H. ;
ten Cate, Hugo .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (18) :1746-1760
[9]   Clinical end points in coronary stent trials - A case for standardized definitions [J].
Cutlip, Donald E. ;
Windecker, Stephan ;
Mehran, Roxana ;
Boam, Ashley ;
Cohen, David J. ;
van Es, Gerrit-Anne ;
Steg, P. Gabriel ;
Morel, Marie-angele ;
Mauri, Laura ;
Vranckx, Pascal ;
McFadden, Eugene ;
Lansky, Alexandra ;
Hamon, Martial ;
Krucoff, Mitchell W. ;
Serruys, Patrick W. .
CIRCULATION, 2007, 115 (17) :2344-2351
[10]   Predictive value of white blood cell subtypes for long-term outcome following myocardial infarction [J].
Dragu, Robert ;
Huri, Shafik ;
Zuckerman, Robert ;
Suleiman, Mahmoud ;
Mutlak, Diab ;
Agmon, Yoram ;
Kapellovich, Michael ;
Beyar, Rafael ;
Markiewicz, Walter ;
Hammerman, Haim ;
Aronson, Doron .
ATHEROSCLEROSIS, 2008, 196 (01) :405-412